← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
British Columbia Cancer Agency Branch
$2,661,535
Total funding
7
Grants
Funding over time
peak $936.8K · FY2009–15$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
DOD$2,661,535 · 7
By mechanism
—$2,661,535 · 7
Investigators at British Columbia Cancer Agency Branch
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
BLOOD-BASED BIOMARKERS FOR LUNG CANCER EARLY DETECTION AND EVALUATION OF CT-BASED LESIONS$936,793
· FY2010 · Department of the Army
INHIBITION OF THE ANDROGEN RECEPTOR AMINO-TERMINAL DOMAIN BY A SMALL MOLECULE AS TREATMENT FOR CASTRATE RESISTANCE PROSTATE CANCER$451,314
· FY2011 · Department of Defense
TROL OF DISEASE RECURRANCE BY TUMOR-INFILTRATING T CELLS IN OVARIAN CANCER$431,420
· FY2009 · Department of the Army
DECIPHERING THE ADAPTIVE IMMUNE RESPONSE TO OVARIAN CANCER$388,068
· FY2012 · Department of the Army
TARGETING COMMON BUT COMPLEX PROTEOGLYCANS ON BREAST CANCER CELLS AND STEM CELLS USING EVOLUTIONARY REFINED MALARIA PROTEINS$235,840
· FY2013 · Department of Defense
ROLE OF TIRAP IN MYELODYSPLASTIC SYNDROMES$129,382
· FY2013 · Department of Defense
CHIMERIC AMINO ACID REARRANGEMENTS AS IMMUNE TARGETS IN PROSTATE CANCER$88,718
· FY2015 · Department of Defense